SCHEMBL6672239

SCHEMBL6672239

O=c1c(O)cccn1C1OC(CO)C(O)C1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.60
CDA P32320 1/20 0.60
SLC5A2 P31639 2/20 0.60
SLC28A1 O00337 1/20 0.56
SLC28A2 O43868 1/20 0.56
SLC29A1 Q99808 1/20 0.56
SLC28A3 Q9HAS3 1/20 0.56
LMNA P02545 2/20 0.53
MTOR P42345 2/20 0.53
THRB P10828 1/20 0.53
MDM2 Q00987 1/20 0.53
NCOA1 Q15788 1/20 0.53
NCOA3 Q9Y6Q9 1/20 0.53
ALDH1A1 P00352 2/20 0.47
HTT P42858 2/20 0.47
BLM P54132 2/20 0.47
GMNN O75496 1/20 0.47
TP53 P04637 1/20 0.47
NFKB1 P19838 1/20 0.47
DNMT1 P26358 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2787204 0.82 SLC5A2 (0.57) MAPTCDASLC5A2SLC28A1SLC28A2
SCHEMBL2787206 0.82 SLC5A2 (0.57) MAPTCDASLC5A2SLC28A1SLC28A2
SCHEMBL13065488 0.82 SLC5A2 (0.57) MAPTCDASLC5A2SLC28A1SLC28A2
SCHEMBL13065638 0.81 SLC5A2 (0.56) MAPTCDASLC5A2SLC28A1SLC28A2
SCHEMBL13065640 0.80 SLC5A2 (0.55) MAPTCDASLC5A2SLC28A1SLC28A2
SCHEMBL7028245 0.79 MAPT (0.63) MAPTCDASLC5A2SLC28A1SLC28A2
SCHEMBL7028251 0.79 MAPT (0.63) MAPTCDASLC5A2SLC28A1SLC28A2
SCHEMBL9293543 0.79 MAPT (0.63) MAPTCDASLC5A2SLC28A1SLC28A2
SCHEMBL12594319 0.79 SLC29A1 (0.52) MAPTCDASLC5A2SLC28A1SLC28A2
SCHEMBL13065339 0.78 SLC5A2 (0.58) MAPTCDASLC5A2SLC28A1SLC28A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004037159-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING FAT METABOLISM OBETHERAPY BIOTECHNOLOGY (FR) 2004-05-06 WO disclosed